Cibus, Inc. (NASDAQ:CBUS) Shares Sold by FineMark National Bank & Trust

FineMark National Bank & Trust cut its holdings in shares of Cibus, Inc. (NASDAQ:CBUS) by 50.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 20,500 shares of the company’s stock after selling 20,488 shares during the quarter. FineMark National Bank & Trust owned 0.08% of Cibus worth $57,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. IFP Advisors Inc acquired a new stake in shares of Cibus in the fourth quarter worth $36,000. B. Riley Wealth Advisors Inc. acquired a new stake in Cibus during the 3rd quarter worth about $44,000. Virtu Financial LLC purchased a new position in shares of Cibus during the 3rd quarter valued at about $48,000. HighTower Advisors LLC lifted its holdings in shares of Cibus by 20.6% in the 3rd quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock valued at $52,000 after buying an additional 2,750 shares during the period. Finally, Sei Investments Co. purchased a new stake in shares of Cibus in the fourth quarter worth about $49,000. 33.81% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CBUS has been the subject of several recent research reports. HC Wainwright reiterated a “buy” rating and set a $25.00 price target on shares of Cibus in a research report on Friday, March 21st. Canaccord Genuity Group decreased their target price on shares of Cibus from $20.00 to $18.00 and set a “buy” rating for the company in a research note on Wednesday, January 22nd.

Cibus Trading Down 5.3 %

NASDAQ CBUS opened at $1.98 on Thursday. The stock has a market capitalization of $52.38 million, a price-to-earnings ratio of -0.09 and a beta of 2.04. The stock has a 50-day moving average of $2.31 and a 200 day moving average of $3.27. Cibus, Inc. has a twelve month low of $1.80 and a twelve month high of $22.99.

Cibus (NASDAQ:CBUS) last announced its earnings results on Thursday, March 20th. The company reported ($0.87) earnings per share for the quarter, missing the consensus estimate of ($0.68) by ($0.19). Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%. The business had revenue of $1.21 million for the quarter, compared to analyst estimates of $1.13 million. Equities analysts predict that Cibus, Inc. will post -2.96 EPS for the current fiscal year.

Cibus Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.